U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807580) titled 'Progesterone in Gender Affirming Hormone Therapy Study' on Jan. 29.
Brief Summary: This study aims to study the effects of Oral Progesterone in Transgender Women. The primary goal is to study the effect of progesterone on psychological distress and secondarily on sleep quality, breast size, quality of life and gender congruence and cardiovascular risk.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Transgender Women
Intervention:
DRUG: Placebo
The placebo will be nearly identical in size, color, and shape to micronized progesterone
DRUG: Progesterone
Oral micronized progesterone 200 mg
Recruitment Status...